News tagged with 'Lilly'

Eli Lilly & Co.has had an FDA expert panel meeting canceled over its application to expand the use of its antidepressant, Cymbalta.

Atypical antipsychotics used in young patients for the first time led to a weight gain of anywhere from 11 to 19 pounds in just 11 weeks and an increase in cholesterol and triglycerides, making some question whether the drugs are a long-term solution for young people with psychiatric disorders.

Merck along with other drug companies realize that transparency will be required under health care reform. As promised, it has issued a list of doctors who it pays to promote its products and educate the public.

Access to doctors by drug sales reps are down 13 percent, according to a new report.  That translates to about $2 billion a year in expenses and salaries lost to pharmaceutical giants supporting the 90,000 reps who make up the U.S. sales force.  Six percent of doctors reportedly will not see reps from any company.

It is a drug that appears to return the bone building process in the elderly to that of  a young persons. Forteo, by Eli Lilly, reduced the healing time from a difficult and painful pelvic fracture by half, say University of Rochester Medical Center researchers. The drug could save money and lives.   

Eli Lilly will have to pay the federal government more than $1.4 billion to settle an off-label marketing scheme for its prescription drug, Zyprexa. The settlement is the largest amount paid by a single defendant in the history of the Department of Justice and was initiated by six former Lilly drug marketing representatives who became whistleblowers over the aggressive off-label marketing for the antipsychotic.

Hoping to continue the success of its blockbuster antipsychotic drug, Zyprexa, Eli Lilly has suffered a setback in its request for FDA approval of a longer-lasting formulation. Zyprexa is mired in controversy about the side effects and allegations that Lilly withheld important safety information.  

Emory University psychiatrist, Dr. Charles Nemeroff has been accused of breaking federal research rules by taking in $2.8 million from a drug company and not reporting half of the income. Sen. Charles Grassley is shaking up the rampant conflict-of-interest relationships between doctors and pharmaceutical makers.  Two drug companies say they will voluntarily disclose payments to doctors online next year.

A new class of diabetes drugs has shown promising results in a clinical trial conducted to help bring it to market. If approved, liraglutide would be the second GLP-1 diabetes medicine approved by the FDA for sale in the U.S. Byetta was the first.

Drug makers are suddenly eager to disclose their payments to doctors and researchers for consulting, and speaking services as a federal government disclosure act is close to becoming law. Consumers will have more information to make informed decisions about health care and influence.

A federal district court judge granted a motion to unseal hundreds of confidential documents about Zyprexa, Eli Lilly’s popular antipsychotic drug. The decision came as part of another ruling granting class-action status to a case brought by pension funds, labor unions and insurance companies that want Eli Lilly to reimburse them for millions of dollars overspent on Zyprexa.

Eli Lilly and Amylin Pharmaceuticals now say there have been four deaths associated with their drug for type-2 diabetes, Byetta.  Amylin shares plunged by 24 percent at midday after executives disclosed Tuesday night the additional deaths "in the interest of transparency."